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Vascular endothelial growth factor (VEGF) is a secreted mitogen which specifically stimulates proliferation of vascular
endothelial cells in vitro and in vivo. Its expression pattern is consistent with it being an important regulator of
asculogenesis and angiogenesis, and targeted disruption of VEGF-A has demonstrated that it is essential for vascular
evelopment. To determine if VEGF-A was sufficient to alter vascularization in the eye we generated transgenic mice which
xpress human VEGF-A165 specifically in the lens. Expression of transgenic VEGF-A led to excessive proliferation and
accumulation of disorganized angioblasts and endothelial cells around the lens. The results support the hypothesis that
VEGF-A can initiate the process of vascularization by stimulating chemoattraction and proliferation of angioblasts and
endothelial cells and that VEGF-A expression can stimulate angiogenic remodeling. However, VEGF-A alone was not
sufficient to direct blood vessel organization or maturation. © 2000 Academic Press
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The initial embryonic vasculature is established through
a process know as vasculogenesis (Risau et al., 1995). The
migration of angioblasts during vasculogenesis is driven by
expression of vascular endothelial cell growth factor (VEGF)
in the embryo and expression of the VEGF receptor FLK-1
(also know as VEGFR2) in the angioblasts (Flamme et al.,
1995a; Dumont et al., 1995; Shalaby et al., 1995). The
oining of progenitor cells to form vessel walls occurs
uring differentiation of angioblasts into vascular endothe-
ial cells. The initial capillary network is extensively re-
odeled to form a vascular tree with large and small
rteries and veins and interconnecting fine capillary net-
orks. The processes regulating vascular remodeling and
rowth have been collectively termed angiogenesis and are
lso regulated by expression of VEGF in the surrounding
issue (reviewed in Risau, 1997). In humans, five VEGF-A
sotypes are produced from alternatively spliced transcripts
1 To whom correspondence should be addressed at current ad-
dress: Department of Ophthalmology, Dean A. McGee Eye Insti-
tute, University of Oklahoma Health Sciences Center, 608 Stanton
L. Young Blvd. Oklahoma City, Oklahoma 73104. Fax: (405)a271-3721. E-mail: john-ash@ouhsc.edu.
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All rights of reproduction in any form reserved.f a single gene, which result in secreted proteins of 121,
45, 165, 189, and 206 amino acids (Poltorak et al., 1997).
ice have four VEGF-A isotypes, three of which are pro-
uced from similar splice variants that encode the human
21, 165, and 189 proteins, but the mouse cDNA has a
nique splice variant that encodes a protein of 115 amino
cids (Shima et al., 1996; Sugihara et al., 1998). In both
pecies the VEGF-A164 is by far the most abundant and is the
ost potent mitogen for vascular endothelial cells. Mice
hat are homozygous for a null mutation in the VEGF-A
ene die around 8.5 to 9.5 days after fertilization due to
evere defects in vascularization (Carmeliet et al., 1996).
he absence of vascular cells in the anterior end of VEGF-A
ull embryos, the scant population of endothelial cells, and
he lack of blood vessel organization in the posterior end
uggest that VEGF-A is essential for endothelial cell sur-
ival, proliferation, and vascular organization. Two high-
ffinity VEGF-A receptors, VEGFR1 (also known as Flt-1)
nd VEGFR2 (also known as Flk-1), are expressed by angio-
lasts and vascular endothelial cells (Millauer et al., 1993;
innerty et al., 1993). Targeted mutations in mice have
emonstrated that both receptors are essential for unique
teps in vascular development (Shalaby et al., 1995; Fong et
l., 1999).
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384 Ash and OverbeekTo investigate the role of VEGF-A in vascular develop-
ment of the eye, we created transgenic mice that express
human VEGF-A165 in the lens. A schematic drawing of the
vasculature in the normal embryonic eye is shown in Fig.
1A. The embryonic lens vasculature, known as the tunica
vasculosa lentis (TVL), is simple and provides a unique in
ivo model system to study the effects of VEGF-A on
igration, proliferation, and differentiation of angioblasts
uring early eye development. The lens vasculature in mice
egins to degenerate after birth and is completely regressed
t weaning (3 weeks) (Jack, 1972). We analyzed prenatal and
ostnatal mice to determine if VEGF-A could function as an
ndothelial cell survival factor and prevent vascular regres-
ion around the lens. The transgenic mice show dramatic
hanges in the TVL architecture, but interestingly, there
as no vascularization of the lens interior. The most
ramatic change was an enhanced migration and prolifera-
ion of angioblasts around the embryonic lens. The angio-
lasts accumulated into a dense vascular bed which did not
rganize into well-defined blood vessels. This early pheno-
ype provides in vivo evidence that VEGF-A can promote
asculogenesis by stimulating proliferation and migration
f angioblasts. The phenotype in postnatal mice suggests
hat while VEGF-A can stimulate endothelial cell survival,
roliferation, and angiogenic remodeling, it is insufficient
o stimulate blood vessel maturation. The developmental
hanges that occur in the lens vascular bed are consistent
ith the hypothesis that blood vessel maturation requires
n appropriate balance of VEGF-A with other vascular
aturation signals.
MATERIALS AND METHODS
Generation and Screening of Transgenic Mice
Transgenic mice were generated using an aA-crystallin–VEGF-A
minigene (Fig. 1B). To generate this minigene a 596-bp BamHI
fragment containing the human VEGF-A cDNA (obtained from Dr.
Bill LaRochelle, NIH) encoding the 165-amino-acid form of
VEGF-A was inserted into a BamHI site downstream of a minimal
360-bp aA-crystallin promoter (Reneker et al., 1995). To generate
transgenic mice the 1.8-kb crystallin–VEGF-A minigene (Fig. 1B)
was released from the plasmid vector by NotI digestion followed by
agarose gel electrophoresis. The fragment was purified using a
quick spin gel extraction kit (Qiagen) and eluted in 10 mM
Tris–HCl pH 7.4, 0.1 mM EDTA. The DNA (diluted to 2 ng/ml) was
icroinjected into pronuclei of one-cell stage FVB/N embryos
Taketo et al., 1991; Hogan et al., 1996). Injected embryos were
mplanted into pseudopregnant ICR females for normal gestation
nd delivery. To identify transgenic mice, genomic DNA samples
ere isolated from tail biopsies and were analyzed using polymer-
se chain reaction (PCR). Founder mice were mated to FVB/N mice
o establish transgenic families.
PCR Analyses
PCR amplifications were carried out using a sense primer (Pr-4,
GCATTCCAGCTGCTGACGGT) which anneals to sequences
2165 to 2146 in the aA-crystallin promoter and an antisense
Copyright © 2000 by Academic Press. All rightprimer (SV40-B, GTCCTTGGGGTCTTCTACCTTTCTC) which
anneals to the SV40 sequences (Fig. 1B). PCRs (50 ml) consisted of
-ml DNA samples, 10 mM Tris–HCl (pH 8.3), 50 mM KCl, 1.5 mM
MgCl2, 0.1% gelatin, 25 mM each dNTP, 4 mM each primer, and 2.5
units of Taq DNA polymerase (Perkin–Elmer Cetus). Reactions
were denatured at 94°C for 2 min, then subjected to 30 cycles of
94°C for 30 s, 58°C for 30 s, and 72°C for 1 min. A 15-ml aliquot
from each reaction was analyzed for the presence of a 1.1-kb
amplification product by electrophoresis in a 1% agarose gel.
In Situ Hybridizations
In situ hybridizations were carried out using 35S-labeled ribo-
probes as described previously (Robinson et al., 1995). A transgene-
specific riboprobe was generated by in vitro transcription of a
plasmid containing the SV40 sequences indicated in Fig. 1B. To
detect mFlt-1 expression, an 800-bp SacI fragment corresponding to
the 59 end of the mouse Flt-1 cDNA (obtained from Clive R. Wood,
Genetics Institute, Inc.) was subcloned into Bluescript and then
linearized with SalI and transcribed with T7 RNA polymerase. To
detect Flk-1, a plasmid containing a 2.6-kb fragment encoding the
extracellular domain of murine Flk-1 (obtained from Werner Risau,
Max-Planck-Institute) was linearized with EcoRI and transcribed
with SP6 RNA polymerase. To detect Tie2, a plasmid containing
1.3 kb of the mouse Tie2/Tek cDNA (obtained from Dan Dumont,
Mount Sinai Research Institute, Toronto, Canada) was linearized
with XhoI and transcribed with SP6. To visualize expressing cells,
silver grains in the dark-field images were colored red in PhotoShop
and overlaid onto the bright-field images. The red color indicates
the location of expressing cells.
Tissue Preparation and Routine Histology
Eyes were enucleated and fixed in 10% formalin for 24 h prior to
dehydration and embedding in paraffin. All histological procedures
were carried out on 5-mm paraffin sections which had been depar-
affinized in xylene and rehydrated in an ethanol series. Sections
were stained with hematoxylin and eosin for routine histology.
Cell Proliferation Assay
Incorporation of 59-bromo-29-deoxyuridine (BrdU) was used to
assess cell proliferation as described previously (Fromm et al.,
1994). BrdU [100 mg BrdU/g body weight (Sigma Chemicals) and 6
mg 59-fluoro-29-deoxyuridine/g body weight (Sigma Chemicals) in
phosphate-buffered saline (PBS)] was injected into animals 1 h prior
to euthanasia. Anti-BrdU antibody (Dako; Cat. No. m744) was
diluted 1:100 in blocking solution and incubated on the tissue
sections for 1 h at 37°C or overnight at 4°C. Sections were washed
three times in PBS, then incubated for 1 h with a secondary
antibody diluted 1:200 in blocking solution. The avidin–biotin
peroxidase detection system (Vector Laboratories) and the indicator
substrate diaminobenzidine–H2O2 were used to detect antibody
complexes. Positive reactions result in the deposit of an insoluble
brown precipitate.
Immunofluorescence
To detect collagen IV protein and laminin in situ, paraffin-
embedded sections were deparaffinized and rehydrated as stated
previously. Tissue sections were predigested with Ficin (diluted
1:200 in PBS; Sigma; F-4125) for 30 min at 37°C, to unmask
s of reproduction in any form reserved.
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385Transgenic Expression of VEGF-AFIG. 1. Embryonic lens vasculature. The mouse embryonic day 15.5 (E15.5) ocular vasculature is depicted (A). The hyaloid artery enters
the eye from the optic nerve head and extends branches through the vitreous (Barishak, 1992). The hyaloid artery and all of its branches
are collectively known as the hyaloid vascular system (Jack, 1972). The first branches lie suspended in the vitreous between the surface of
the retina and the lens and are known as the vasa hyaloidea propria (VHP). Subsequent branches extend toward the lens and run along its
surface. These vessels are part of the lens vasculature known as the tunica vasculosa lentis (TVL). The TVL does not penetrate the lens but
instead lies adjacent to the lens capsule. The anterior TVL is composed of a capillary plexus located in the pupillary membrane lying on
the anterior surface of the lens. The aA-crystallin–VEGF minigene (B) consists of a 360-bp aA-crystallin promoter (black arrow) linked to
596-bp human VEGF-A cDNA and SV40 early sequences, which provide intron and polyadenylation signals. The VEGF-A cDNA encodes
he 165-amino-acid form of VEGF-A. The locations of the annealing sites for the primers Pr4 and SV40B which were used to identify
ransgenic mice are shown. To measure transgene expression by in situ hybridization, riboprobes corresponding to the SV40 sequencesshown in the shaded region were used.
Copyright © 2000 by Academic Press. All rights of reproduction in any form reserved.
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386 Ash and Overbeekantigen. Sections were washed three times in PBS and then
incubated in blocking solution (10% horse serum in PBS) for 1 h at
room temperature. Sections were then incubated overnight at 4°C
with either a rabbit anti-collagen IV antibody (Chemicon; AB765)
diluted 1:100 in blocking solution or a rabbit anti-laminin antibody
(Sigma; L9393) diluted 1:30 in blocking solution. Sections were
washed three times in PBS and then incubated for 1 h at room
temperature with a Cy3-labeled anti-rabbit secondary antibody
(Jackson Laboratories; 111-165-144), diluted 1:200 in blocking
solution (to detect collagen IV), or with an FITC-labeled anti-rabbit
secondary antibody (Vector Laboratories; FI-1000), diluted 1:75.
Smooth muscle actin was detected using an FITC-labeled anti-
smooth muscle actin antibody (Sigma; F3777) diluted 1:500 in
blocking solution overnight, then washed three times in PBS to
remove unbound antibody. After the final wash, all slides were
mounted in 50% glycerol–PBS containing 2 mg/ml DAPI (Sigma) to
label nuclei. Fluorescent complexes were detected using a Leica
DMRB fluorescence microscope.
Scanning EM
To analyze the lens vasculature by scanning EM, tissue samples
were fixed overnight in 3% glutaraldehyde in 0.1 M sodium
cacodylate. After fixation samples were washed three times in 0.1
M cacodylate buffer. The sclera and retina were dissected from one
side of the eye to reveal the vasculature on the surface of the lens.
Tissues were postfixed in 1% osmium tetroxide in 0.1 M cacody-
late buffer, washed three times in distilled water, and then dehy-
drated in a graded acetone series and subjected to three critical
point drying runs. Samples were then mounted and sputter coated
with tungsten and palladium. Coated samples were examined
using a Joel JSM 6100 microscope.
RESULTS
Crystallin–VEGF-A Transgenic Mice
aA-crystallin–VEGF-A minigene (Fig. 1B) was used to
generate three independent transgenic lines (OVE 702, 703,
and 704). As the families had similar phenotypes, trans-
genic line OVE 703 was chosen for analysis. The phenotype
of animals was analyzed at embryonic day 11.5 (E11.5),
E12.5, E13.5, E14.5, E15.5, E18.5, day of birth (PO), postna-
tal day 5 (P5), P7, P10, P14, and P21. At least two animals
were analyzed for each age. This age range was chosen to
observe the effects of VEGF-A on development of the
embryonic lens vasculature and on subsequent TVL regres-
sion.
Transgenic VEGF-A Enhances Early Lens
Vascularization
We observed very little difference between normal and
transgenic eyes at E12.5, with only a modest increase in the
number of cells on the posterior and lateral sides of the lens
in transgenic eyes (Fig. 2B) compared to normal eyes (Fig.
2A). In nontransgenic eyes, these cells are angioblasts and
endothelial cells, which will give rise to the hyaloid vascu-
lar system that is well established by E14 (Fig. 2C). In
transgenic animals, significantly more of these cells accu-
Copyright © 2000 by Academic Press. All rightulate, so that by E14.5, they had formed into a dense
luster of cells on the lens surface (asterisk, Fig. 2D). In the
itreous of transgenic eyes, hyaloid artery branching was
ore complex than in normal eyes; however, the vessels
id not form a distinct VHP (Fig. 2D). While excess cells
ccumulated around the lens, no cells were observed to
igrate into the lens.
VEGF Expression Causes an Accumulation of
Angioblasts and Endothelial Cells
Expression of the VEGF-A transgene was analyzed by in
situ hybridization to confirm lens-specific expression.
Transgene expression was found only in the lens fiber cells
and was detected as early as E11.5 (Fig. 3A). Transgene
expression was increased in the fiber cells of E12.5 lenses
(not shown) and was expressed at the highest level by E15.5
(Fig. 3B). Transgene expression was also observed at E18
(not shown) and during postnatal development at ages P5
(Fig. 3C) and P14 (Fig. 3D).
Based on their location, morphology, and accumulation
in response to VEGF-A expression, the extra cells surround-
ing the transgenic lenses were expected to be a mixed
population of angioblasts and endothelial cells. To confirm
this prediction, the expression patterns of the high-affinity
VEGF-A receptors Flk-1 and Flt-1, and the tyrosine kinase
receptor Tie2 (or Tek), were analyzed by in situ hybridiza-
ion (Fig. 4). Flt-1 is expressed by nonvascular endothelial
ells including monocytes (Breier et al., 1995; Clauss et al.,
1996); however, no monocytes were identified in the cell
mass using the F480 antibody (not shown). Flk-1 has been
shown to be expressed in the retina (Yang et al., 1996), and
Tie2 is expressed in lens epithelial cells (unpublished ob-
servations). However, only angioblasts and vascular endo-
thelial cells express all three markers. Flk-1 was expressed
by most of the cells surrounding the transgenic E12.5 lens
(Fig. 4B), and the number of cells expressing Flk-1 was
dramatically increased in transgenic eyes, by E15.5. In the
E15.5 transgenic eye most of the accumulating cells also
expressed high levels of Flt-1 and expressed Tie2. A major-
ity of the cells that accumulate around transgenic lenses
express all three receptors, identifying them as either an-
gioblasts or endothelial cells. There were a few cells that
did not express Flk-1 (Fig. 4D) and a few cells that did not
express Flt-1 (Fig. 4E). Cells that did not express Flk-1 (Figs.
4A and 4C) or Flt-1 (not shown) were also observed in
nontransgenic animals. These cells may represent mesen-
chymal cells which can give rise to pericytes. However,
they did not express the pericyte marker smooth muscle
actin (not shown).
VEGF-A Induces Localized Vascular Cell
Hyperplasia
The incorporation of BrdU into the DNA of replicating
cells was analyzed to determine if transgenic expression of
s of reproduction in any form reserved.
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387Transgenic Expression of VEGF-AVEGF-A was affecting cell proliferation. In both nontrans-
genic and transgenic E12.5 eyes, many of the cells around
the lens stained positive for BrdU incorporation, indicating
a high rate of proliferation (arrows, Figs. 5A and 5B).
BrdU-positive cells in serial sections demonstrated similar
proliferation rates in E12.5 transgenic and nontransgenic
eyes, with 39 and 38% of the cells around the lens in S
phase at the time of sacrifice (Table 1). In the nontransgenic
E15.5 eye (Fig. 5C), the percentage of BrdU-positive cells
FIG. 2. Transgenic VEGF-A enhances intraocular vascularization.
lens and the retina (A). The abundance of these cells increased sligh
a clearly identifiable TVL on the surface of the lens is seen in nontr
cluster of cells accumulated on the surface of the lens (D). The ma
The vascular branching from the hyaloid artery (h) was more exten
ens; h, hyaloid artery; od, optic disc.decreased to 22% (Table 1), while in transgenic E15.5 eyes o
Copyright © 2000 by Academic Press. All righthe rate of proliferation remained high with 31% of the cells
ositive for BrdU (Fig. 5D and Table 1). The proliferation of
yaloid cells in the nontransgenic E18 eye decreased
harply to 9%, and no positive cells were observed in the
VL of nontransgenic newborn mice (Table 1). In contrast,
eonatal and postnatal transgenic animals continued to
ave elevated cell proliferation rates, although the rates
ecreased with age (Table 1). The peak of angioblast and
ndothelial cell proliferation was coincident with the peak
ntransgenic E12.5 eyes (ntg) vascular cells accumulate between the
n the transgenic (tg) E12.5 eyes (B). The lens vascular system with
enic E14.5 eyes (arrow, C). In age-matched transgenic eyes, a dense
of these cells were not organized into blood vessels (asterisk, D).
in transgenic eyes (C and D). Scale bars, 100 mm. Abbreviations: l,In no
tly i
ansg
jority
sivef transgene expression at E15.5.
s of reproduction in any form reserved.
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388 Ash and OverbeekAngiogenic Remodeling in the Postnatal
Vascular Bed
To study the fate of the angioblasts and endothelial cells,
we analyzed perinatal and postnatal eyes by histology. On
the surface of the E18 transgenic lens, the vascular bed was
composed of several layers of blood vessels (Figs. 6B and
6C). In addition, the vasa hyaloidea propria (VHP) was less
extensive and was disorganized compared to normal (Fig.
6A). In transgenic P0 eyes (Fig. 6E), the VHP was still poorly
organized compared to that of nontransgenic eyes (Figs. 6D
and 6E). The vascular bed in transgenic P0 eyes (Fig. 6F)
consisted of single layers of abnormal vessels with large
dilated lumen-like structures with unusually thin walls
(arrowheads, Fig. 6F). The conversion of small multilayered
vessels to single layered and dilated vessels suggested
extensive vascular remodeling. Numerous pillars of endo-
FIG. 3. Lens-specific expression of transgenic VEGF-A. In situ hyb
in the transgene RNA was used to demonstrate lens-specific trans
indicate 50 mm (A and B) and 500 mm (C and D).thelial cells and matrix (Fig. 7A) were observed in the P0 i
Copyright © 2000 by Academic Press. All rightascular bed, further suggesting angiogenic remodeling.
ost of the cells in the vascular bed were positive for the
EGF-A receptors Flt-1 and Flk-1 by in situ hybridization
not shown). In P5 transgenic animals, the number and size
f blood vessels were visibly reduced. Most of the space
ithin the vascular bed was filled with cells (Fig. 7B). A few
emaining channels containing red blood cells were evi-
ent; however, the majority of the cells were not obviously
ntegrated into organized blood vessels (Fig. 7B). In some
egions of the P14 vascular bed, there was a significant
eduction in the number of cells, with the majority of the
emaining cells organized into blood vessels (Fig. 7C).
owever, in other regions the vascular bed remained disor-
anized (Fig. 7D). In the P21 transgenic eyes, well-defined
lood vessels of various sizes were evident (Figs. 7E and 7F).
ome of the vessels had a high density of endothelial cells
nd thick basement membranes (Fig. 7E). Pericytes express-
ation using an 35S-labeled riboprobe specific to the SV40 sequences
expression at E11.5 (A), E15.5 (B), P5 (C), and P14 (D). Scale barsridiz
geneng smooth muscle actin were associated with many of the
s of reproduction in any form reserved.
c
o
b
v
P
r
d
r
r
8
. Ab
389Transgenic Expression of VEGF-Ablood vessels in the P21 transgenic eye (arrowheads, Figs.
7E and 7F).
To further characterize the postnatal vascular remodel-
ing, P5, P14, and P21 eyes were analyzed by scanning
electron microscopy. At P5 the surface of the transgenic
vascular bed had a uniform covering of matrix (vb, Fig. 8B).
Some of the surface material was removed during dissection
to observe the structure underneath (Fig. 8B). Analysis of
this region suggests that the vascular cells have formed a
spongiform vascular bed lying on the surface of the lens.
FIG. 4. Expression of angioblast and endothelial cell markers. Exp
kinase receptor Tie-2 (F) was assayed by in situ hybridization usi
indicated probe. A and C are images of nontransgenic control eyes at
and D–F are images of transgenic eyes at E15.5. Scale bars, 100 mmThe vascular bed appears to have channels which would be h
Copyright © 2000 by Academic Press. All rightapable of transporting blood (1, Fig. 8B). In some regions
n the surface of the P14 transgenic lens there were distinct
lood vessels (Figs. 8D and 8E). However, in other areas the
ascular bed was similar to that in P5 eyes (not shown). By
14 the vessel density of the normal TVL was dramatically
educed (Fig. 8C). The blood vessels were collapsed and
iscontinuous with obvious gaps between terminals (ar-
ows, Fig. 8C). In addition, numerous tissue-specific mac-
ophages (hyalocytes) were evident (large arrowheads, Fig.
C), which are thought to play a role in the regression of the
on of the VEGF receptors Flk-1 (A–D) and Flt-1 (E) and the tyrosine
S-labeled riboprobes. The red color indicates hybridization to the
5 and E15.5, respectively. B is an image of a transgenic eye at E12.5,
breviations: l, lens; r, retina.ressi
ng 35
E12.yaloid vascular system (HVS) (Lang et al., 1993, 1994).
s of reproduction in any form reserved.
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390 Ash and OverbeekNumerous macrophage-like cells were also present on the
surface of the transgenic P14 lens (round cells on top of the
vessels, Figs. 8D and 8E). By P21 in the normal eye, the HVS
TABLE 1
BrdU Incorporation
Age Transgenic vascular cells
Nontransgenic
vascular cells
12.5 38 6 4%a 39 6 7%a
E15.5 31 6 2%b 22 6 3%b
E18.5 18 6 4%b 9 6 3%b
P0 10 6 2%b No incorporation
5 14 6 1%b ND
14 6 6 2%b ND
21 3 6 1%b ND
Note. ND, not determined.
a BrdU-positive cells as a percentage of ,200 cells counted in
adjacent sections.
FIG. 5. VEGF-A-induced hyperplasia. BrdU incorporation was us
ntg, A and C) and transgenic (tg, B and D) animals at ages E12.5
ndicate proliferating cells. Scale bars, 100 mm. Abbreviations: l, leb Greater than 1000 cells counted.
Copyright © 2000 by Academic Press. All rightas almost completely regressed (not shown). In the P21
ransgenic eye, the entire lens surface was covered by blood
essels of various sizes (Fig. 8F). Some of the larger vessels
ppear to branch into smaller vessels (arrow, Fig. 8F). Most
f the vessels were oriented in a posterior to anterior
irection along the lens surface.
Developmental Changes in Basement Membrane
Synthesis
Localization of collagen IV and laminin was used to
determine if cells around the lens were maintaining an
appropriate basement membrane. The high-density cell
mass in E15.5 transgenic eyes (asterisk, Fig. 9A) had very
low levels of collagen IV. These same cells were positive for
laminin (Fig. 9B). However, at higher magnification (not
shown) it was apparent that laminin was localized within
the cytoplasm of the cells rather than in an organized
basement membrane. At later ages collagen IV and laminin
had similar localizations. Both collagen IV (Fig. 9C) and
laminin (not shown) were uniformly distributed throughout
measure the proliferation rate of vascular cells in nontransgenic
d B) and E15.5 (C and D). Brown-stained nuclei (arrows A and B)
, retina.ed tothe vascular bed around the E18.5 transgenic lens and were
s of reproduction in any form reserved.
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391Transgenic Expression of VEGF-Apredominately localized in the basement membranes of the
multilayered vessels (v, Fig. 9C). In P0 transgenic eyes, both
proteins were found in the outer fibrous layer of the
vascular bed and in the ribbons of matrix that extended into
the enlarged vessels (arrow, Fig. 9D). By P5, almost all of the
cells in the vascular bed were positive for collagen IV (Fig.
9E). The distinct blood vessels around the lenses of P14 (not
FIG. 6. Neonatal vascular organization. Nontransgenic (ntg) E18 e
the VHP (arrow) is near the surface of the developing retina. The V
vitreous (arrow, B). Several layers of blood vessels (v, C) were appar
(white arrow, C). The transgenic P0 eye had a remnant of the VHP
surface of the P0 vascular bed. The curved arrows in C and E indishown) and P21 (Fig. 9F) transgenic eyes demonstrated
Copyright © 2000 by Academic Press. All rightntense laminin (not shown) and collagen IV staining in
heir basement membranes.
Environmental Changes of the Lens Vascular Bed
In postnatal transgenic lenses, the fiber cells degenerated
(manuscript in preparation), and fluid accumulated in the
) has a well-developed TVL, lying on the surface of the lens (l), and
n the transgenic E18 eye (B and C) was much less organized in the
n the surface of the E18 lens. Note the large vessel in the vitreous
w, E), and a single layer of enlarged vessels (arrowheads, F) on the
he boundary between the lens and the vascular bed.ye (A
HP i
ent o
(arrocenter of the lens (Fig. 10). By P5 the lens is well separated
s of reproduction in any form reserved.
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392 Ash and Overbeekfrom the retina (Fig. 10A), but by P14, some areas of the lens
surface make contact with the retinal surface (arrows, Fig.
10B). Improved blood vessel differentiation first occurred in
these areas of contact. By P21 the lenses had expanded to fill
FIG. 7. Histology of vascular organization changes. To analyze th
transgenic eyes were stained with hematoxylin and eosin. In eac
boundary. Note the large irregularly shaped blood vessels in the P0
endothelial cell pillars. The P5 transgenic lens (B) was surrounded b
the red blood cells in small channels within the cellular bed. The
of distinct but irregularly shaped blood vessels (C). Around other reg
found in the P5 vascular bed (D). In P21 transgenic eyes (E and F), w
a basement membrane, and pericytes (arrowhead, E), which were
(arrowhead, F). Scale bar, 10 mm.the space within the eye, so that most of the lens vascular v
Copyright © 2000 by Academic Press. All righted became juxtaposed to the inner surface of the retina
Fig. 10B). The maturation of the lens vascular bed appeared
o be enhanced at this age, perhaps as a consequence of
nteractions with proteins from the adjacent retina and its
ular organization in the remodeling vascular bed, 5-mm sections of
age, the vascular bed is below the lens and the arrows mark the
genic vascular bed (A). Most of the vessels were separated by single
ense bed of cells, most of which expressed Flk-1 (not shown). Note
lar bed in some regions of the P14 transgenic lens was composed
of the P14 lens, the vascular bed retained the spongiform structure
rmed blood vessels were present and consisted of endothelial cells,
tified by immunofluorescence detection of smooth muscle actine cell
h im
trans
y a d
vascu
ions
ell-fo
idenasculature.
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393Transgenic Expression of VEGF-ADISCUSSION
We have generated three independent lines of transgenic
mice that express human VEGF-A165 specifically in the lens.
xpression was observed as early as E11.5 with continued
xpression through P21 (expression at later times was not
etermined). Transgenic synthesis of VEGF-A resulted in
FIG. 8. Angiogenic remodeling in the vascular bed. Scanning EM
he structure of the normal TVL for this age. (B) Transgenic 5-day-ol
he transgenic lens. Some of the matrix was removed during disse
ascular channels (1, B). (C) A postnatal day 14 (P14) nontransgen
essel that was in the process of degeneration. Numerous macroph
arrowheads, C). The vascular bed in some regions of the lens in P
and E). However, most were dilated and irregular. In E, the cu
tructures are seen on the entire lens surface (F). All of the vesse
ranching (arrow, F). Scale bars, 100 mm.he formation of a vascular bed around the lens, which q
Copyright © 2000 by Academic Press. All rightnderwent dynamic change as the animals aged (summa-
ized in Fig. 11). The nature of the lens vascular bed
uggests that VEGF-A participates in vasculogenesis as a
otent mediator of angioblast migration and proliferation
nd also participates in angiogenesis as a mediator of
ndothelial cell proliferation and reorganization. The re-
ults also demonstrate that blood vessel development re-
omicrographs. (A) Nontransgenic 5-day-old (P5) eye demonstrating
demonstrating a matrix covering the vascular bed (vb) surrounding
to reveal the structure of the vascular bed underneath. Note the
g) eye showing the degenerating TVL. The arrow in C indicates a
(hyalocytes) can be seen on the surface of the nontransgenic lens
ansgenic (tg) eyes had resolved into distinct blood vessels (arrows,
s of blood vessels can be seen (arrows). By P21 prominent vessel
re aligned posterior to anterior (anterior is up) and exhibit somephot
d eye
ction
ic (nt
ages
14 tr
t end
ls weuires a balance between VEGF-A and coordinating signals.
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394 Ash and OverbeekInterestingly, we did not observe vascular tissue within the
lens itself, despite the fact that the VEGF-A concentration
FIG. 9. Basement membrane synthesis. Immunolocalization of col
are major components of blood vessel basement membranes and
high-density cell mass in E15.5 transgenic eyes (asterisk, A) had very
Cells in the cell mass nearest the E15.5 lens (B) had pericytoplasmi
sufficiently to acquire a polarized characteristic. Collagen IV and
therefore, only collagen IV is shown for subsequent ages. Collagen
P0 transgenic eyes, collagen IV was found in the outer fibrous laye
into the dilated vessels (arrow, D). By P5 most of the cells were
well-defined basement membranes (E). The distinct blood vessel
demonstrated intense collagen IV staining localized to basement m
(l) and the vascular bed. Blood vessels in the retina (r) and the innshould be highest within this tissue. This suggests that the a
Copyright © 2000 by Academic Press. All rightnvironment within the lens is inhibitory for vascular
nvasion. The mechanism for this inhibition is not known
IV (red) and laminin (green fluorescence) is shown. These proteins
analyzed to determine the extent of vascular organization. The
levels of collagen IV compared to the blood vessels in the vitreous.
inin staining, suggesting that these cells had not yet differentiated
nin antibodies gave similar patterns of staining at all other ages;
as localized to vascular basement membranes in E18.5 eyes (C). In
he vascular bed, with some protein detected as ribbons extending
tive for collagen IV; however, the protein was not distributed to
und the lenses of P14 (not shown) and P21 transgenic eyes (F)
ranes. The blue and red lines mark the boundary between the lens
iting membrane of the retina were also positive.lagen
were
low
c lam
lami
IV w
r of t
posi
s arot this time.
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Copyright © 2000 by Academic Press. All rightVEGF-A Expression Enhances Vasculogenesis but
Is Not Sufficient to Direct Blood Vessel
Organization
An impressive mass of Flt-1- and Flk-1-positive cells
accumulates around the lenses of E15.5 transgenic animals,
and excessive microvessels form in the vitreous. The vas-
cular bed at E15.5 is composed of mixed cell populations,
most of which are angioblasts or endothelial cells based on
Flk-1, Flt-1, and Tie2 expression. The distinction between
angioblasts and endothelial cells currently is not clearly
defined by molecular markers. Therefore, we must rely on
morphological classification to distinguish between these
related cell types. The dense cluster of cells nearest to the
E15.5 transgenic lens (Fig. 2D) lack distinct blood vessels
with organized basement membranes (Figs. 9A and 9B),
suggesting that these cells are angioblasts. Cells farther
away from the E15.5 lens are positive for collagen IV and
laminin and are forming blood vessels, suggesting that
these cells have differentiated into endothelial cells.
During normal vasculogenesis in the embryo, the expres-
sion pattern of VEGF-A is consistent with the hypothesis
that it provides a chemoattractant and mitogenic signal to
angioblasts (Breier et al., 1992, 1995; Dumont et al., 1995;
Koch et al., 1994). In the VEGF-A transgenic mice we
bserved evidence for both roles. Shortly after the onset of
ransgene expression, we observed a small increase in the
umber of angioblasts around the lens that cannot be
ccounted for by increased proliferation rates. This obser-
ation suggests that VEGF-A is a chemoattractant for
ascular endothelial progenitors. The role of VEGF-A as a
hemoattractant for angioblasts has recently been demon-
trated in Xenopus development (Cleaver et al., 1998). If
transgenic eyes (A), the lens vascular bed is separated from the
retina by a substantial vitreous space. In P14 eyes (B), the lens
vascular bed begins to make contact with the retina (arrows). Blood
vessels are first apparent at these sites. In P21 eyes (C), the retina is
often detached from the RPE and is attached to the lens vascular
FIG. 11. Developmental changes in the transgenic-lens vascular
bed.FIG. 10. Well-formed blood vessels are coincident with contact of
the retina. Hematoxylin- and eosin-stained sections showing
changes in the spatial relationship between the lens (l) and thebed. Scale bar, 500 mm.
s of reproduction in any form reserved.
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396 Ash and OverbeekVEGF-A were a guidance signal for angioblast migration,
then the absence of a chemoattractant signal could explain
the abnormal distribution of endothelial cells observed in
embryos that lack VEGF-A (Carmeliet et al., 1996). By
15.5, we observed excessive accumulation of angioblasts
nd endothelial cells, which can be attributed to a persis-
ent high rate of proliferation. This demonstrates that
EGF-A is a potent mitogen for angioblasts as well as
ndothelial cells. The role of VEGF-A as a mitogen for
ngioblasts suggests that the reduction of endothelial cells
een in VEGF-A null mice could be the result of impaired
roliferation of endothelial stem cells as well as endothelial
ells (Ferrara et al., 1996; Carmeliet et al., 1996).
Despite the accumulation of angioblasts around the lens,
he cells do not efficiently organize into mature blood
essels, suggesting that VEGF-A stimulation alone is not
ufficient for blood vessel development. It is unlikely that
EGF-A-induced proliferation directly inhibits organiza-
ion of vessels, since the nontransgenic E15.5 HVS had a
igh BrdU index (22%) and well-defined blood vessels (Fig.
). A more likely model predicts that the normal HVS is a
apidly growing and organized vascular network because
here is a balance between the VEGF-A proliferation signal
nd the collaborating organizational signals. Near the lens
n the transgenic eye, where the VEGF-A concentration
ould be highest, this balance would be shifted dramati-
ally toward proliferation, leading to the accumulation of
roliferating cells that do not form blood vessels. At a
istance from the transgenic lens, VEGF-A levels would be
ower and the balance in signals would be more favorable
or vessel organization, allowing the overgrowth of blood
essels seen at a distance from the lens in the E15 eye (Fig.
D).
VEGF-A Stimulates Angiogenic Remodeling in
Postnatal Eyes
During the late embryonic and early postnatal develop-
ment (E18–P14), the vascular bed around the transgenic
lenses appears to be undergoing constant remodeling. The
distinct blood vessels observed in the vascular beds of E18
and P0 animals were positive for collagen IV and laminin,
suggesting that the angioblasts had differentiated into en-
dothelial cells. The E18 transgenic vasculature consisted of
several layers of blood vessels lying on the lens surface. The
histology suggests that the multilayered vessels were not
stable, and by P0, they had fused together to form thin-
walled and dilated vessels. VEGF-A-stimulated fusion of
small vessels to form large vascular sacs was also observed
when exogenous VEGF-A was applied to quail embryos
during the time of normal vasculogenesis (Drake et al.,
995). In the eyes of transgenic mice the dilated vessels also
ere not stable and became filled-in with proliferating
ndothelial cells by P5, so that the abnormal vessels were
estricted to small channels percolating through a dense
ascular bed. These early postnatal changes are evidence
Copyright © 2000 by Academic Press. All righthat VEGF-A alone does not promote stable vascular struc-
ures.
Excess VEGF-A expression in the developing limb buds of
hicks has been shown to induce localized hypervascular-
zation (Flamme et al., 1995b). In addition, VEGF-A has also
een used as a therapeutic agent to promote collateral
ascularization around blocked arteries in the brain, in
yocardium, and around ischemic vessels in limbs (Baum-
artner et al., 1998; Hayashi et al., 1998; Rivard et al., 1998).
In all of these environments VEGF-A alone appears suffi-
cient to promote blood vessel development. The apparent
ability of VEGF-A to stimulate the growth and organization
of blood vessels in some tissues, but not around the neona-
tal lens, suggests that organization of blood vessels is
environment dependent. Permissive or nonpermissive en-
vironments may be determined by the abundance of orga-
nizational signals relative to the VEGF-A proliferation
signal. In permissive environments, VEGF-A can stimulate
proliferation of endothelial cells, which organize into blood
vessels due to sufficient levels of collaborating organiza-
tional signals. In a nonpermissive environment, the col-
laborating signals are not at sufficient levels to promote the
development of organized vessels, resulting in endothelial
cell proliferation and vascular remodeling. An obvious
interpretation for the inability of VEGF-A alone to form
vessels in neonatal transgenic eyes is that organizational
signals may be significantly underrepresented relative to
the VEGF-A signal. Alternatively, the lens may express
factors that inhibit vascular development on its surface.
However, this seems unlikely since the normal lens is
vascularized by the TVL at this age, and well-organized
blood vessels were observed in P21 transgenic mice.
The correlation between blood vessel differentiation and
proximity to the retina suggests that the mechanism of
enhanced maturation is more complicated than a simple
reduction in VEGF-A levels. It is more likely that the retina
may be the source for vascular organizational signals. The
biological response of endothelial cells to VEGF-A has been
suggested to depend on the presence of other signals pro-
duced by surrounding tissues (Suri et al., 1996, 1998;
Maisonpierre et al., 1997; Hanahan, 1997). During the first
and second postnatal weeks, the retinal vasculature is
developing; therefore, the retina must be sending all neces-
sary signals for growth and organization of blood vessels. As
the lens vascular bed approaches the retina, the localized
concentration of these signals would increase. The poor
organization of blood vessels in early postnatal transgenic
mice suggests that the levels of the collaborating signals are
not sufficient to balance the excess VEGF-A, resulting in
hyperproliferation and poor vascular organization. With the
combination of decreasing VEGF-A levels with age and
increasing levels of collaborating signals as the vascular bed
nears the retina, the balance is shifted to favor blood vessel
differentiation. Indeed, evidence that the retina can pro-
mote blood vessel differentiation has been demonstrated by
the organization of ectopic vessels in transgenic mice
expressing VEGF-A in photoreceptors (Tobe et al., 1998;
s of reproduction in any form reserved.
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tion of vessels without excessive cellular accumulation.
Alternatively, it is possible that poor blood vessel develop-
ment in early postnatal VEGF-A transgenic mice is the
result of an insufficient population of mesenchymal cells
and pericytes to interact with the overabundance of vascu-
lar endothelial cells. Perturbations in endothelial-
mesenchymal cell ratios have also been described as a
mechanism to explain the vascular defects in mice that
have a null mutation in the VEGF-A receptor Flt-1 (Fong et
al., 1999). A possible consequence of this cellular imbalance
may be an inadequate supply of essential blood vessel
differentiation signals like angiopoietin-1 (Suri et al., 1996,
1998; Sato et al., 1995) or the activation of TGFb-1, which
s also essential for blood vessel maturation (Dickson et al.,
995). The late development of blood vessels when the lens
s in proximity to the retina may be the result of recruiting
etinal astrocytes or pericytes from the retinal vasculature.
The VEGF-A-transgenic mice provide a useful in vivo
odel system in which to study the combinatorial role of
olecular signals which coordinate vascular development.
y expressing coactivators of vascularization along with
EGF-A in transgenic lenses we should be able to study the
ffects of these factors on vascular cell proliferation, orga-
ization, or cell death in vivo.
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